Abstract: In one embodiment, an integrated circuit (IC) device includes a first logic block having performance characteristics, a first critical path monitor (CPM) configured to monitor the performance characteristics of the first logic block, and a first CPM envelope circuit enveloping the first CPM. The first logic block is configured to operate in at least one of a first functional mode and a first scan mode. The first CPM is adapted to operate in at least one of a second functional mode and a second scan mode. The first and second functional modes use higher clock frequencies, respectively, than the first and second scan modes. The first CPM envelope circuit comprises a clock-gate circuit adapted to allow the IC device to operate in a mixed mode, wherein the first CPM operates in the second functional mode while the first logic block operates in the first scan mode.

Abstract: In one embodiment, an integrated circuit (IC) device includes a first logic block having performance characteristics, a first critical path monitor (CPM) configured to monitor the performance characteristics of the first logic block, and a first CPM envelope circuit enveloping the first CPM. The first logic block is configured to operate in at least one of a first functional mode and a first scan mode. The first CPM is adapted to operate in at least one of a second functional mode and a second scan mode. The first and second functional modes use higher clock frequencies, respectively, than the first and second scan modes. The first CPM envelope circuit comprises a clock-gate circuit adapted to allow the IC device to operate in a mixed mode, wherein the first CPM operates in the second functional mode while the first logic block operates in the first scan mode.

Abstract: An expandable medical device includes a plurality of elongated struts, forming a substantially cylindrical device which is expandable from a first diameter to a second diameter. A plurality of different beneficial agents may be loaded into different openings within the struts for delivery to the tissue. For treatment of conditions such as restenosis, different agents are loaded into different openings in the device to address different biological processes involved in restenosis and are delivered at different release kinetics matched to the biological process treated. The different agents may also be used to address different diseases from the same drug delivery device. In addition, anti-thrombotic agents may be affixed to at least a portion of the surfaces of the medical device for the prevention of sub-acute thrombosis. To ensure that the different agents remain affixed to the device as well as to each other, masking and de-masking processes may be utilized.

Abstract: The invention provides a method for single-step terminal sterilization process for bio-active heparin coatings on materials and biomaterials containing heparin used in medical devices, such as catheters, tissue engineering scaffolds, or drug delivery carrier materials. This may include any medical device or implantable that could benefit from improved antithrombotic and biocompatible heparin surfaces. Other relevant device examples may include heparin or a heparin derivative coated stents to reduce clotting and restenosis, dental or ophthalmological implants. These materials may comprise additional polymeric compositions such as polyethyleneimine, dextran sulfate or their modified forms. These polymers together with heparin coatings may be applied to other substrate of medical devices such as metal, ceramics or biologically derived materials.

Abstract: The invention provides a method for single-step terminal sterilization process for bio-active heparin coatings on materials and biomaterials containing heparin used in medical devices, such as catheters, tissue engineering scaffolds, or drug delivery carrier materials. This may include any medical device or implantable that could benefit from improved antithrombotic and biocompatible heparin surfaces. Other relevant device examples may include heparin or a heparin derivative coated stents to reduce clotting and restenosis, dental or ophthalmological implants. These materials may comprise additional polymeric compositions such as polyethyleneimine, dextran sulfate or their modified forms. These polymers together with heparin coatings may be applied to other substrate of medical devices such as metal, ceramics or biologically derived materials.

Abstract: An expandable medical device includes a plurality of elongated struts, forming a substantially cylindrical device which is expandable from a first diameter to a second diameter. A plurality of different beneficial agents may be loaded into different openings within the struts for delivery to the tissue. For treatment of conditions such as restenosis, different agents are loaded into different openings in the device to address different biological processes involved in restenosis and are delivered at different release kinetics matched to the biological process treated. The different agents may also be used to address different diseases from the same drug delivery device. In addition, anti-thrombotic agents may be affixed to at least a portion of the surfaces of the medical device for the prevention of sub-acute thrombosis. To ensure that the different agents remain affixed to the device as well as to each other, primer layers may be utilized.

Abstract: An expandable medical device includes a plurality of elongated struts, forming a substantially cylindrical device which is expandable from a first diameter to a second diameter. A plurality of different beneficial agents may be loaded into different openings within the struts for delivery to the tissue. For treatment of conditions such as restenosis, different agents are loaded into different openings in the device to address different biological processes involved in restenosis and are delivered at different release kinetics matched to the biological process treated. The different agents may also be used to address different diseases from the same drug delivery device. In addition, anti-thrombotic agents may be affixed to at least a portion of the surfaces of the medical device for the prevention of sub-acute thrombosis. To ensure that the different agents remain affixed to the device as well as to each other, masking and de-masking processes may be utilized.

Abstract: An expandable medical device includes a plurality of elongated struts, forming a substantially cylindrical device which is expandable from a first diameter to a second diameter. A plurality of different beneficial agents may be loaded into different openings within the struts for delivery to the tissue. For treatment of conditions such as restenosis, different agents are loaded into different openings in the device to address different biological processes involved in restenosis and are delivered at different release kinetics matched to the biological process treated. The different agents may also be used to address different diseases from the same drug delivery device. In addition, anti-thrombotic agents may be affixed to at least a portion of the surfaces of the medical device for the prevention of sub-acute thrombosis. To ensure that the different agents remain affixed to the device as well as to each other, primer layers may be utilized.

Abstract: An expandable medical device includes a plurality of elongated struts, forming a substantially cylindrical device which is expandable from a first diameter to a second diameter. A plurality of different beneficial agents may be loaded into different openings within the struts for delivery to the tissue. For treatment of conditions such as restenosis, different agents are loaded into different openings in the device to address different biological processes involved in restenosis and are delivered at different release kinetics matched to the biological process treated. The different agents may also be used to address different diseases from the same drug delivery device. In addition, anti-thrombotic agents may be affixed to at least a portion of the surfaces of the medical device for the prevention of sub-acute thrombosis. To ensure that the different agents remain affixed to the device as well as to each other, masking and de-masking processes may be utilized.

Abstract: An expandable medical device includes a plurality of elongated struts, forming a substantially cylindrical device which is expandable from a first diameter to a second diameter. A plurality of different beneficial agents may be loaded into different openings within the struts for delivery to the tissue. For treatment of conditions such as restenosis, different agents are loaded into different openings in the device to address different biological processes involved in restenosis and are delivered at different release kinetics matched to the biological process treated. The different agents may also be used to address different diseases from the same drug delivery device. In addition, anti-thrombotic agents may be affixed to at least a portion of the surfaces of the medical device for the prevention of sub-acute thrombosis. To ensure that the different agents remain affixed to the device as well as to each other, primer layers may be utilized.

Abstract: A test clocking scheme that separates the clock driving the functional logic and the memory from the clock driving the test logic and the memory. In other words, the test clocking scheme separates the memory functional clock from the memory test clock into two clock paths. The test clocking scheme provides for the ability to separately shut off either the memory functional clock source or the memory test clock source, provides that less power is required during production testing, and provides that simulation time is reduced during design verification because the functional logic is not clocked.

Abstract: A method of generating a truncated scan test pattern for an integrated circuit design includes steps of: (a) receiving as input an integrated circuit design; (b) estimating a number of transition delay fault test patterns and a corresponding number of top-off stuck-at fault patterns to achieve maximum stuck-at fault and transition delay fault coverage; (c) truncating the estimated number of transition delay fault patterns to generate a truncated set of transition delay fault patterns so that the truncated set of transition delay fault patterns and the corresponding number of top-off stuck-at fault patterns achieve maximum stuck-at fault and transition delay fault coverage within a selected scan memory limit; and (d) generating as output the truncated set of transition delay fault patterns and the corresponding number of top-off stuck-at fault patterns.

Abstract: A method of testing a core module includes steps of: (a) providing a core module of an integrated circuit design; (b) connecting an end user input and a core module test input to separate I/O pins of the core module to isolate logic associated with an end user signal from that associated with a core module test signal; and (c) multiplexing the end user signal and the core module test signal in the core module in response to a core module test mode signal.

Abstract: A wireless receiver apparatus including a voltage controller oscillator and mixer. The voltage controlled oscillator generates a first signal having a first frequency, and a second signal having the first frequency. The first and second signals are in quadrature. The mixer has a first input port for receiving the first signal, and a second input port for receiving the second signal, a third input port for receiving a third signal at a frequency centered about a third frequency. The mixer generates a fourth signal having a frequency centered about a fourth frequency which is equal to the third frequency less twice the first frequency.

Abstract: An adaptive equalization and baseline wander correction circuit has an adaptive filter loop and an independent baseline wander correction loop by using dual halfwave rectifiers and peak detectors with capacitors to store the peak DC value of the incoming signal to be shared between the two loops.

Abstract: A driver circuit is provided comprising a detection circuit, configured to sense a plurality of different variable operating condition signals, and in accordance therewith, provide a plurality of operating condition dependent output signals; a selection circuit, having a plurality of output signals, configured to receive said plurality of operating condition dependent output signals, and in accordance therewith, discretely enable, during a non-transmission state, an N number of enabled output signals; and an output circuit, having a plurality of identical segmented output modules, each of the output modules associated with a respective one of the plurality of output signals and configured to provide a respective output driving signal, wherein the output modules associated with the N number of enabled output signals each provide the output driving signal.

Abstract: A driver circuit is provided comprising a detection circuit, configured to sense a plurality of different variable operating condition signals, and in accordance therewith, provide a plurality of operating condition dependent output signals; a selection circuit, having a plurality of output signals, configured to receive said plurality of operating condition dependent output signals, and in accordance therewith, discretely enable, during a non-transmission state, an N number of enabled output signals; and an output circuit, having a plurality of identical segmented output modules, each of the output modules associated with a respective one of the plurality of output signals and configured to provide a respective output driving signal, wherein the output modules associated with the N number of enabled output signals each provide the output driving signal.

Abstract: A low noise amplifier circuit is operable in two gain modes: high gain (approximately 15 dB) and low gain or attenuation (approximately −5 dB), with a number of gain paths. In the low gain or attenuation path, the frequency response is improved by adding a diode-connected transistor and a capacitor connected in series and operating as a filter, which effectively puts a pole (p=−1/RL Ct) in the peak of the high frequency response.

Abstract: An improved current mode driver circuit uses N-type transistors in current mirrors to achieve higher speed operation at lower cost. A pair of matched low frequency P-type transistors provide a small amount of current to each side of the differential amplifier which comprise of only N-type transistors in a current mirror connection to amplify the current supplied thereto.

Abstract: A monolithic microwave oscillator using a negative resistance cell includes a resonator, a negative resistance cell that employs an active device, an output buffer for voltage and current amplification, and a field effect transistor. The negative resistance cell includes a bipolar junction transistor as its active device, with the output buffer circuit coupled to a base of the BJT through the field effect transistor. The combination of the resonator and the negative resistance cell produce a periodic RF microwave signal that is sampled, amplified and buffered by the buffer circuit without degradation.